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Objective: To determine the microbial etiology of acute community-acquired pneumonia in Yaounde.
Methods: Ninety-one consecutive adult patients admitted to hospital for radiologically confirmed acute community-
acquired pneumonia were studied prospectively. Sputum microscopy and culture, blood cultures, pneumococcal antigen
detection in serum and serologic analysis for agents of atypical pneumonia and for human immunodeficiency virus (HIV)
were performed for most patients.
Results: There were 65 men and 26 women, mean age 36.5 years. Of 91 patients, 70.3% had at least one predisposing
factor and 21.7% (20 of 81) were seropositive for HIV. A microbial etiology was identified in 48 (52.7%) cases. A single
pathogen was identified in 42 (85.4%\ and double pathogens in six (14.6%\. Bacteremia occurred in 12 of 81 patients and
was significantly more common in HIV-seropositive than in HIV-seronegative patients. Streptococcus pneumoniae was
the commonest causative agent, identified in 22 of 91 (24.2%) patients, 10 of whom were bacteremic. Atypical pathogens
were diagnosed in 14 of 65 patients with serologic tests. Mycoplasma pneumoniae and Coxiella burnetiiwere diagnosed
in six of 65 (9.2%) cases each, and Chlamydia pneumoniae in three (4.6%) patients. Mycoplasma pneumoniae and
Chlamydia pneumoniae occurred as a dual infection in one case. Seven of 91 patients died, and death was not associated
with any particular etiology.
Conclusion: Streptococcus pneumoniae remains the predominant etiologic pathogen of community-acquired
pneumonia. For this reason, and also because ampicillin used empirically to treat patients with this disease in the same
setting has been shown to be efficacious, we propose the use of an aminopenicillin in the initial treatment of acute
community-acquired pneumonia in adults in Yaounde. However, patients who fail to respond clinically to such treatment
should benefit from either a macrolide or a tetracycline in order to cover for atypical pathogens.
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INTRODUCTION
Acute community-acquired pneumonia is among
the commonest causes of adult admission to hospital,
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accounting for about 10% of all adult medical
admissions in Sub-Saharan Africa [1]. It remains a
serious health problem worldwide and represents an
important cause of morbidity and mortality in the
tropics [2]. Despite many new and potent antibiotics,
the mortality is between 5% and 10% [3,4]. In
developed countries numerous causal agents of com-
munity-acquired pneumonia have been identified and
newer pathogens are still being discovered [5]. In
contrast, because of limited resources and lack of
diagnostic facilities, very little is known about the
microbial etiology of this disease in many developing
African countries.
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The aim of this study was to investigate the micro-
bial etiology of community-acquired pneumonia in
adult hospitalized patients in Yaounde so that empirical
antibiotic therapy could be proposed.
PATIENTS AND METHODS
All consecutive adult patients, aged 1S years and above,
admitted between December 1991 and February 1993,
in the infectious disease service of the Central Hospital
(CH) and the chest unit of Jamot Hospital (JH) in
Yaounde, with acute community-acquired pneumonia
were studied prospectively. Medical history and
physical examination of all patients were recorded on a
pre-established form for this purpose. Predisposing
factors, including alcohol intake, smoking, diabetes,
chronic obstructive pulmonary disease (COPD), malig-
nancy and chronic administration of corticosteroids, as
well as previous treatment before consultation, were
obtained for each patient.
The diagnosis of pneurTlonia was made on admis-
sion ifpatients had a history and clinical signs consistent
with an acute lower respiratory tract infection and a
fresh infiltrate on their chest X-ray. All chest radio-
graphs were routinely interpreted by a radiologist in the
CH and reviewed by our chest physician in the JH.
Patients with tuberculosis and those in whom a sub-
sequent course excluded a pneumonic process were not
included in the study.
Bacteriologic study
Twenty milliliters of venous blood were collected
aseptically for culture from 81 patients on admission
and before antibiotic treatment was instituted. Ten
milliliters were inoculated into each of two bottles
containing 100 mL of trypticase soy broth (bio-
Merieux, France) and incubated at 3S 0c. Blood
cultures were examined macroscopically for evidence
of bacterial growth twice daily the first day and once
daily thereafter for 7 days. Turbid blood cultures
were examined microscopically after Gram stain, and
subcultured on 5% sheep blood, chocolate and
MacConkey agars. MacConkey plates were incubated
in air at 3S °C for 18 h. Blood and chocolate (heated
blood) plates were incubated for 18 h at 35°C in a
candle extinction jar with a humid atmosphere during
the first 3 months of our study only. Because the jar was
no longer available after this, they were subsequently
incubated in air at 35°C for 18 h.
We identified pneumococci on the basis ofcolonial
morphology, hemolytic reaction on blood agar and
susceptibility to S.O-I-lg oprochin disk (inhibition zone
> 15 mm) (BBL, USA). Other streptococcal species
were identified on the basis of colonial morphology,
hemolytic reaction, negative catalase reaction and sero-
logic tests for group determination (Slidex Streptokit,
bioMerieux, France). Staphylococcal species were
characterized by colonial morphology, positive catalase
test, coagulase production (lyophilized rabbit plasma,
bioMhieux, France), deoxyribonuclease production
(Dnase Agar, Diagnostic Pasteur, France) and mannitol
fermentation (Mannitol salt agar, Diagnostic Pasteur,
France). Gram-negative bacilli were characterized using
API 20E (bioMerieux, France). Haemophilus species
were characterized by their growth requirement for X
and V factors (X and V factors strips, BBL, USA) on
trypticase soy agar (bioMhieux, France). Moraxella
catarrhalis was identified by colonial morphology, positive
oxidase reaction and other biochemical reactions using
the biochemical identification scheme for Neisseriaceae
(Diagnostic Pasteur). Bacteria isolated from blood
cultures were considered etiologic agents ofpneumonia
only if the same organism was found in two blood
cultures, except for StreptococCHS pneumoniae, which was
considered the causal pathogen when isolated in a
single blood culture.
Sputum samples were also collected within 24 h of
admission from 70 patients with productive cough, and
processed by Gram stain and culture. Only samples
showing greater than 25 polymorphonuclear leuko-
cytes and less than 10 squamous epithelial cells per low-
power field were cultured [6]. Cultures were performed
on 5% sheep blood agar (bioMerieux, France) streaked
with a I)-hemolytic Staphylococcus aureus to reveal
Haemophilus by satellitism and on MacConkey agar
(bioMerieux, France). Incubation ofplates and bacterial
identification followed the same procedure described
for blood isolates. Bacteria isolated from sputum
cultures were considered etiologic pathogens if they
were compatible with the predominant organisms
present on Gram stain and if cultured in abundant
growth or in pure culture.
Antigen detection
Pneumococcal antigen (PCA) was sought in samples of
serum from 81 patients by latex agglutination test
(Slidex pneumokit, bioMerieux) as described pre-
viously [7,8]. The presence of PCA in serum was
considered diagnostic of pneumococcal pneumonia.
Serologic tests
Acute and convalescent sera were collected from all
patients on admission and 10-15 days later, when
possible. Sera were stored at -20°C and sent frozen
in a refrigerated box to the microbiology laboratory
of H6pital Broussais in Paris, France for serologic
analysis. Sera from 65 patients were tested for anti-
bodies to Coxiella hurnetii and Chlamydia pneumoniae by
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an indirect immunofluorescence test (IF). They were
tested for antibodies to Mycoplasma pneumoniae by
ELISA for IgG (Sorin BioMedica, Italy) and by immune
capture ELISA (Sanofi-diagnostics Pasteur, France) for
IgM antibodies. A serum titer for phase II antigen of
IgG 1:200 and IgM 1: 50 was considered positive for
Cox. burnetii infection [9]. Chlam. pneumoniae serology
was considered positive if the IgG titer was > 512 and
IgM 32 [10]. The presence of IgM antibodies to M.
pneumoniae and/or a fourfold or greater increase in IgG
titers in convalescent serum was considered evidence of
a recent infection.
Statistical analysis
Association between categorical variables were deter-
mined using the chi-squared test. A statistical signifi-
cance was considered established ifP<0.05.
RESULTS
Ninety-one patients (65 men, 26 women) aged between
17 and 75 years (mean 36.5±14.8) were studied. Sixty-
four patients (70.3%) had at least one predisposing
factor: 42 patients (46.2%) consumed alcohol, 38
(41.8%) were current smokers, three had diabetes
mellitus and four suffered from COPD. No patient had
a malignant disease and none was undergoing treatment
with corticosteroids. Only 27 (29.7%) of the 91 patients
had no underlying disease or predisposing factor. Forty-
five of 91 patients (49.5%) had not received any
treatment before consultation, 30 (32.9%) had taken
an antibiotic and the rest (17.6%) had received some
unknown medication. The antibiotics most often
taken were: penicillin G, seven patients; amoxicillin or
ampicillin, 21 patients; erythromycin, one patient; and
roxithromycin, one patient. Gentamicin was taken in
combination with amoxicillin in two cases, while
thiophenicol was taken in combination with penicillin
or amoxicillin in one case each. The main clinical
findings on admission were cough (96.7%), fever
(94.5%), chest pain (89.1%), dyspnea (86.1 %), sputum
production (82.4%), chills (68.1%) and crackling rales
(83.5%). Chest radiographs of91 patients showed three
patterns: alveolar (77 cases, 84.6%), interstitial (13 cases,
14.3%) and mixed (one case, 1.1%). Fourteen patients
(15.4%) had evidence of pleural effusion.
In 48 of 91 patients (52.7%) an etiologic diagnosis
was made, and 54 etiologic agents were identified. A
single etiologic pathogen was identified in 42 patients
(85.4%) and double pathogens in six (14.6%). Table 1
shows the relative frequencies of etiologic agents, and
the characteristics of 48 patients with a known micro-
biological diagnosis and those of 43 with undetermined
etiology.
Bacteria were cultured and/or pneumococcal
capsular antigen was detectable in specimens from 37
of 48 patients. Sputum cultures alone gave a diagnostic
aid in 23 patients, blood cultures in 12 patients and
serum PCA alone in two patients. Agents of atypical
pneumonia were diagnosed by serology in 14 patients
(Table 2). Bacterial agents occurred in mixed infections
with atypical microbial agents in three patients. Styep.
pneumoniae was the most prevalent bacterium, repre-
senting 22 of 48 (45.8%) diagnosed cases, followed by
Staph. aureus with 6 (12.5%) and Klebsiella pneumoniae
with 5 (10.4%). Bacteremia occurred in 12 of 81
patients (14.8%) in whom blood cultures were done.
Ten cases of bacteremia were due to Strep. pneumoniae
and two to Staph. aureus.
Table 1 Etiologies and characteristics of 48 patients with known etiologies of acute community-acquired pneumonia and 43
patients with undetermined etiology
Patients HIV'
tested Sex Mean age positive Death
Organism No. isolated (no.) % M/F (yean) (no.) (no.)
Streptococcus pneumotliae 22 91 24.2 16/6 37.0 6 3
Mycoplasma pneumoniae 6 65 9.2 5/1 32.8 1 0
Coxiella bumetii 6 65 9.2 5/1 41.3 0 1
Staphylocoalls aureus 6 91 6.6 4/2 35.2 3 I
Klebsiella pneumoniae 5 91 5.5 2/3 44.5 0 0
Chlamydia pneumoniae 3 65 4.6 3/0 23.3 0 0
Haemophilus influenzae 2 91 2.2 210 25.0 1 0
Moraxella catarrhalis 2 91 2.2 2/0 37.0 0 0
Streptococcus pyogenes 2 91 2.2 2/0 26.5 0 0
Unknown 43 91 47.3 24/13 34.7 9 2
Total 97b 91 65/26 36.5 20 7
•Eighty-one patients were tested for both HIV infection and bacterial pathogens, while only 65 of these were tested for atypical pathogens.
bDual etiologies were diagnosed in six patients.
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Table 3 Microorganisms diagnosed in six mixed infectionsTable 2 Microbial etiology and diagnostic methods of
acute corrununity-acquired pneumonia in 48 patients with
determined diagnosis Patient's
number Organisms
Organisms and methods yielding
bacterial diagnosis
Streptococcus pl1cumoniae
Blood culture
Sputum culture only
Serum PCA' only
Frequency
10
lOb
2
5
21
45
60
73
79
Streptococcus pneumoniae + Mycoplasma pneummtiae
Streptococcus pneumoniae + Mycoplasma pneumoniae
Streptococcus pneumoniae + Streptococcus pyogenes
Chlamydia pneumoniae + Mycoplasma pneumoniae
Streptococcus pneumoniae + Klebsiella pneumoniae
Streptococcus pneumoniae + Coxiella burnetii
'PCA =pnellmococcal capsular antigen.
bIn one case each Streptococcus pneumoniae was isolated in mixed
infections with Klebsiella pneumoniae and Streptococcus pyogenes.
'Atypical pathogens include: Mycoplasma pneumoniae (6),Coxiella
bumerii (6) and Chlamydia pneumoniae (3). Mycoplasma pneumoniae
was diagnosed in dual infections with Chlamydia plleumoniae in one
patient.
Staphylococcus aureus
Blood culture
Sputum culture only
Klebsiella plleumoniae
Sputum culture
Haemophilus ilifluCIlzae
Sputum culture
I>1oraxella catarrhalis
Sputum culture
Strep/"{O{{US PY"'~etU~
Sputum culture
Atypical pathogens'
Serology
2
4
2
2
15
Fourteen of 65 patients (21.5%) whose sera were
available for analysis for agents of atypical pneumonia
had evidence of infection. Infections due to M. pneu-
moniae and Cox. burnetii were found in six cases each,
followed by Chlam. pneumoniae infection diagnosed in
only three cases. M. pneumoniae infection was diagnosed
in mixed infections with Chlam. pneumoniae in one
patient. Table 3 shows the microorganisms diagnosed
in mixed infections.
Twenty of 81 (21.7%) patients tested for HIV
antibodies were positive for HIV-l antibodies only. Six
of these had bacteremia as compared to six of 61 HIV
seronegative patients. This difference was significant
(chi2 =4.85, P=O.03). There was no significant differ-
ence between the etiologies of pneumonia in HIV-
seropositive patients and those in HIV-seronegative
patients (P>O.OS).
Table 4 Characteristics of fatal cases
Duration Risk factors Duration of
of illness and Previous hospItal stay
Patient's Age before admission associated antibiotic before death
number (years) Sex (days) illness treatment (days) Etiology
04 22 F 9 HIV CotrimoxJzole 10 Staph. aureus
Bactereluia Erythromycin
Skin abscess
05 19 F 2 HIV Penicillin G 3 Strep. p"eumo"iae
Bacteremia
25 27 M 15 Smoking Ampicillin 3 Unknown
Alcoholism
32 55 F 7 Smoking Ampicillin 5 Cox. burneti;
Alcoholism
Diabetes
62 25 M 2 Smoking Thiophenicol <1 Strep. p"eumo"iae
Alcoholism
Bacteremia
63 25 M Unknown Bacteremia None 5 Strep. pneuma"iae
Meningitis
77 45 M 14 Previous Unknown 16 Unknown
pulmonary
tuberculosis
Severe anemia
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Seven patients (7.7%) died, five of these within the
first 5 days ofhospitalization. All seven patients had one
or more predisposing factors on admission. Four of the
seven patients had bacteremia, and two of these were
HIV positive. The characteristics of the fatal cases are
given in Table 4. Death occurred more signiflcantly in
bacteremic patients than in those with non-bacteremic
pneumonia (chi2==7.52, P=O.Ol), while it was not
associated with HIV status or any specific etiologic
agent (P>0.05)
DISCUSSION
In this study, the etiology ofacute community-acquired
pneumonia was diagnosed in 52.8% of91 patients. This
result falls within the lower limit of published rates of
50%-97% [11,12]. The low diagnostic rate obtained
in our study may be partly due to antibiotic therapy
prior to admission. Antibiotic administration before
admission is known to be significantly associated with
undetermined etiology [5,13] and has been shown to
reduce in particular the identification of the pneumo-
coccus [13]. Given that the antibiotics most often taken
by our patients were potentially active against Strep.
pneumoniae, there is a possibility that the majority ofour
patients with no identifiable cause may have suffered
from bacterial pneumonia, especially pneumococcal
pneumonia. Indeed, in our conununity antibiotics are
commonly sold in the streets and are readily available
over the counter without a prescription. They are also
often added to cough mixtures. About a third of the 91
patients in this study had received some antibiotics
before admission and half had taken some unknown
medications bought in the streets. Technical reasons
may also account for this low rate. Optimum recovery
of Streptococcus and Haemophilus species requires incuba-
tion in an atmosphere rich in C02 (5-10%). This
condition was fulfilled only at the beginning of
our study. The low diagnostic rate in this study may also
be due to the fact that analysis for agents of atypical
pneumonia was performed in only 65 patients. Further-
more, neither Legionella nor viral agents were looked
for, although Legionnaires' disease is said to be rare in
tropical Africa [2] and viruses have been proven to be
rare causes of community-acquired pneumonia
requiring hospitalization in the absence of epidemics
[5].
Strep. pneumoniae etiology was the most common
etiology found in our study. It was responsible for
infection in 22 of 91 patients (24.2%) and represented
45.8% of diagnosed etiologies. Our results are in
agreement with those of several investigators who have
reported Strep. pneumoniae to be the most predominant
microorganism responsible for acute community-
acquired pneumonia [1,5,12-14]. In addition, bac-
teremia has been shown to occur significantly more
frequently in pneumococcal pneumonia compared to
other etiologies [5,15]. This is confirmed by our study,
where 10 of 12 bacteremias were due to Strep.
pneumoniae.
Staph. aureus accounted for 6.6% of all etiologic
agents in our study. This rate is lower than the 9% rate
observed by Moore et al. [16] but far higher than the
rates of 1-2.4% reported by other authors [12,13,17].
Staph. aureus is a known cause of pneumonia in the
elderly and in young patients recovering from influenza
[16,18,19]. Our patients were young (average age 35.2
years, range 31-50 years) and had no clinical history
suggestive of influenza. There was also no history of
epidemics of influenza during the period of our study.
However, some of these patients presented with
underlying conditions which could have favored the
acquisition of staphylococcal bacteremia with sub-
sequent pneumonia. Two of our six patients with
staphylococcal pneumonia had bacteremia (one of
them died), and they were both seropositive for HIV
and had multiple skin abscesses which were possibly the
source of the bacteremia. As has been suggested,
furuncles may signal a source ofbacteremic pneumonia
[18]. A further patient with radiologic evidence oflung
abscess had undergone traditional scarification prior to
his chest infection. Whether scarification served as the
portal of entry of Staph. aureus in this case remains
questionable.
K. pneumoniae was identified in five (5.5%) of 91
patients in our study. Moore et al. [16] reported a rate
of9% in their series. Conversely, much lower rates were
reported by Fang et al. [5] and Marrie et al [20]. In the
study ofMarrie et al., however, strict diagnostic criteria
were used and could explain the difference with
our study. The clinical significance of Gram-negative
bacillus isolates in sputum cultures is difficult to
determine, particularly in elderly patients, in patients
with serious underlying diseases and in those who
have previously been on antibiotics. Such patients
usually have increased oropharyngeal colonization with
these organisms [5,18]. Because of this, according to
Tillotson, cited by Marrie et al. [20], for Gram-
negative bacteria to be considered definite etiologic
agents of pneumonia, the same bacterial species must
be isolated from two or more consecutive sputum
cultures or from blood and sputum cultures in close
temporal proximity or from pleural fluid.
In this study, three of the five patients with K.
pneumoniae infection were elderly (50, 60 and 75 years),
four had two or more underlying conditions (smoking
and alcoholism in four patients, diabetes and COPD in
one each of these four) and a fifth patient had received
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antibiotic therapy prior to admission. Our diagnosis of
K. pneumoniae in these five patients was based only on
its isolation from a single sputum sample per patient.
We considered a heavy or pure growth of this micro-
organism on sputum culture as being diagnostic if
associated with the presence of large Gram-negative
rods on sputum microscopy. However, only one
sputum culture had a pure growth of K. pneumoniae;
moreover, it was isolated from neither blood nor pleural
fluid. Therefore, the identification ofcolonizing organ-
isms in some of these patients cannot be excluded and,
consequently, we cannot ascertain the true incidence of
K. pneumoniae pneumonia in this study.
Pneumonia due to M. pneumoniae was diagnosed
serologically in 9.2% of 65 patients and in 12.5% of
patients with identifiable etiology. Our result is similar
to the 14% found by White et al. in the UK [19] and
lower than the 17% obtained in northern Nigeria by
MacFarlane et al. [21]. However, rates as low as 0-3%
have been reported by other authors [5,12,15]. M.
pneumoniae appears to have a cyclic incidence, with
peaks occurring every 3 years [12,15]. There was no
outbreak of community-acquired pneumonia during
our study period.
We found evidence of Cox. burnetii infection in six
of 65 patients, four of whom had high titers of anti-
Cox. burnetii-specific IgG and IgM antibodies to phase
II antigen (1: 1200, 1:800 and 1:600, 1:400 for IgG, and
1:100,1:400,1:200 and 1:200 for IgM, respectively).
These findings are suggestive of acute Q fever pneu-
monia in these patients. Cox. burnetii infection is known
to be endemic in the adult population in several African
countries [22), and the presence of antibodies to Cox.
burnetii in animals was documented in Cameroon by Le
Noc et al. in 1977 [23]. The fact that animals such as
goats and sheep live in close contact with humans in
most tropical African countries may in part explain this
endemicity.
Although the frequency of Chlam. pneumoniae
infection in our study is low, it is comparable to the
results of other studies [5,20), and indicates the
presence of this newly described microorganism in our
community.
In agreement with some authors [24], we observed
no differences in frequencies of etiology of acute
community-acquired pneumonia between HIV-sero-
positive and HIV-seronegative patients. Nevertheless,
bacteremia occurred significantly more often in HIV-
seropositive patients. Gilks et al. in their series [25]
also showed that bacteremia was significantly more
common in HIV-seropositive than in HIV-seronegative
patients.
In this study, death was significantly associated with
bacteremia but there was no association between HIV
and death. Also, death was not significantly associated
with any particular etiologic agent, although it com-
monly occurred in patients with Strep. pneumoniae
infection. Of the seven patents who died in our study,
three were infected by Strep. pneumoniae; this may
merely be related to the predominance of this
pathogen. Moore et al. [16], in their series of 154 cases,
also found that six of nine deaths occurred in patients
with pneumococcal pneumonia. The low case-fatality
rate in our study may have masked possible associations;
however, data on specific microbial association with
death in community-acquired pneumonia are conflict-
ing [5,13,16,20]. Our results are similar to those of
some authors [5,16]. All the fatal cases in this study had
some underlying co-morbidities, and this has been
reported in almost all other studies.
We conclude that acute community-acquired
pneumonia is most commonly caused by Strep. pneu-
moniae in our locality, as elsewhere; however, 'atypical'
pathogens also play an important etiologic role.
Although Strep. pneumoniae resistant to penicillin has
been documented in some studies from tropical Africa,
strains isolated from the respiratory tract remain usually
sensitive in vivo to these agents and to other f3-lactam
antibiotics [26,27]. We propose, therefore, that peni-
cillins or the aminopenicillins should remain as the
empirical treatment of acute community-acquired
pneumonia in adult patients in Yaounde. However,
macrolides or tetracyclines should be used as alternative
antibiotic therapy whenever a patient fails to respond
to the initial treatment, so as to cover for atypical
pathogens, particularly for Cox. IJUrnetii infection which
seems to be more common in our environment.
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